A224060 Stock Overview
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
THE CODI Co.,LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,580.00 |
| 52 Week High | ₩12,510.00 |
| 52 Week Low | ₩5,130.00 |
| Beta | 0.17 |
| 1 Month Change | -1.76% |
| 3 Month Change | -15.84% |
| 1 Year Change | -16.84% |
| 3 Year Change | -78.86% |
| 5 Year Change | -93.38% |
| Change since IPO | -86.28% |
Recent News & Updates
Shareholder Returns
| A224060 | KR Semiconductor | KR Market | |
|---|---|---|---|
| 7D | -0.9% | -1.0% | -4.3% |
| 1Y | -16.8% | 72.8% | -1.0% |
Return vs Industry: A224060 underperformed the KR Semiconductor industry which returned 72.8% over the past year.
Return vs Market: A224060 underperformed the KR Market which returned -1% over the past year.
Price Volatility
| A224060 volatility | |
|---|---|
| A224060 Average Weekly Movement | 6.1% |
| Semiconductor Industry Average Movement | 8.0% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A224060 has not had significant price volatility in the past 3 months.
Volatility Over Time: A224060's weekly volatility has decreased from 11% to 6% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 62 | n/a | codi-m.com |
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agent for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases.
THE CODI Co.,LTD. Fundamentals Summary
| A224060 fundamental statistics | |
|---|---|
| Market cap | ₩26.34b |
| Earnings (TTM) | -₩7.98b |
| Revenue (TTM) | ₩20.21b |
1.3x
P/S Ratio-3.3x
P/E RatioIs A224060 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A224060 income statement (TTM) | |
|---|---|
| Revenue | ₩20.21b |
| Cost of Revenue | ₩22.00b |
| Gross Profit | -₩1.78b |
| Other Expenses | ₩6.19b |
| Earnings | -₩7.98b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.69k |
| Gross Margin | -8.83% |
| Net Profit Margin | -39.46% |
| Debt/Equity Ratio | 160.5% |
How did A224060 perform over the long term?
See historical performance and comparison